Founded by Fapon Group and Dr. Wesselhoeft (Orna Therapeutics), MOTE is taking aim at one of RNA's most persistent challenges: cell-specific delivery beyond the liver. MOBILIZE LNPs use a bifunctional ...

With Terrana Biosciences, Moderna founder Flagship can apply its RNA knowledge to agricultural use cases like pest and ...

With a $50 million initial investment from Flagship, Terrana will use RNA from benign plant viruses as a chassis to carry ...

The innate immune system is the body's first line of defense against pathogens and foreign substances. An essential component ...

A recent study involving researchers from the University of Basel reveals that slowing down the intracellular transport of ...

Summary: New research reveals how a tiny chemical mark on RNA helps wire the brain during development. Scientists discovered ...

To overcome the inherent challenge of translation termination interference caused by stop codon reprogramming in mammalian ...

The program allows patients to undergo genetic testing and high-resolution retinal imaging anonymously and provide insights ...

While biopharmaceutical technologies have made substantial strides in treating diseases, drug research and development ...

Breast cancer is one of the most common cancers among women in the United States. Thanks to decades of fundamental research, ...

A historic wall at the Brisbane Showgrounds adorned with murals from street artists has been demolished as part of the ...

Plant RNA viruses pose a significant threat to global agriculture, affecting a vast array of crop species and leading to ...